2 active trials 2 recruiting 1 disease areas
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-10-07 | NCT07862647 TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma | Phase 1 | Recruiting |
| Phase 1 | 1 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT07225621 | Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound… | Glioblastoma | Recruiting | 2026-07-17 |
| Phase 1 | ||||
| NCT07862647 | TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma | Glioblastom WHO Grade 4 | Recruiting | 2026-10-09 |
Glioblastoma (2)